On March 17, 2026, Royalty Pharma announced that Greg Butz will join as Executive Vice President, Partnering & Investments effective June. This move expands the leadership team alongside recently appointed Head of Asia Ken Sun. In conjunction, Chris Hite transitions to Chairman, Partnering & Investments to oversee global relationships and deal execution.

Butz joins from Bank of America, where he served as Global Co-Head of Healthcare Investment Banking, advising public and private biopharma firms on capital raises, M&A and strategic transactions. His prior titles include Co-Head North American Healthcare Investment Banking and Head of Life Sciences Investment Banking. He holds a BA from Williams College and an MBA from Dartmouth.

The addition of Butz alongside Ken Sun and Chris Hite positions Royalty Pharma to capitalize on an expanding royalty market and rising transaction volumes. Butz’s expertise in structuring funding solutions and Hite’s relationship network aim to accelerate royalty acquisitions across commercial products and development-stage candidates worldwide.